Objective: To determine the odds of cesarean, operative vaginal delivery and vaginal birth after cesarean after successful external cephalic version (ECV) compared with singleton pregnancies eligible for a trial of labor.
Introduction
Breech presentation complicates 3 to 4% of term pregnancies, and planned vaginal delivery for a singleton, term, breech presentation has been associated with a higher neonatal morbidity than elective cesarean delivery. 1, 2 In an attempt to minimize the risks associated with either breech vaginal delivery or elective cesarean delivery, the American College of Obstetricians and Gynecologists recommended application of external cephalic version (ECV) to reduce breech presentations in singleton gestations. 3 ECV is a safe and effective method that consists of rotating the fetus from breech to cephalic presentation by external manipulation of the mother's abdomen, with the success rate ranging from 44 to 77%. 2, 4 Although the intent of ECV is to decrease the overall cesarean delivery rate for breech presentation, there is controversy as to whether this is ultimately achieved. Some studies have shown an increased rate of cesarean delivery following successful ECV, whereas others have not. [5] [6] [7] [8] [9] [10] [11] [12] Part of the difficulty in drawing a conclusion from these studies is that differing control groups and matching characteristics have been used. In addition, small sample sizes may have been a limiting factor in some studies. Further, many have excluded participants with prior cesarean delivery, making information on this subset of individuals limited. Therefore, the goals of this investigation were to settle the questions as to whether successful ECV truly lowers the rate of cesarean delivery in patients with non-cephalic presentation and whether women undergoing successful ECV have a higher rate of cesarean delivery as compared with those presenting for labor management at term with spontaneous cephalic presentations.
Methods
This is a matched case-control study that was performed at Saddleback Memorial Medical Center, an academically affiliated, community-based hospital. Before study initiation, institutional review board approval for human participant research was obtained from the Memorial Services Office of Research Administration. Cases were identified in a retrospective fashion using a contemporaneously collected, quality assurance perinatal database known as OBStat. Cases were defined as participants with a singleton gestation who underwent a successful ECV for malpresentation during the study period from 1 January 1998 to 31
July 2006. The obstetric and perinatal information of this study population was retrieved from the Memorial Care OBStat Database. The information in this database is entered by a trained clinical nurse and is checked weekly for accuracy.
During the study period, the clinical protocol of the department was to offer ECV to women with a breech presentation at 36 weeks' gestation or beyond. ECV was not offered or performed if the patient had any of the following contraindications: multifetal pregnancy, placenta previa, third trimester bleeding, oligohydramnios (amniotic fluid index <5), premature rupture of membranes, intrauterine growth restriction, previous uterine surgery other than prior low-transverse cesarean section, gross fetal anomalies, nonreassuring fetal heart tracing or uterine anomaly. Breech vaginal delivery for the term, singleton gestation was not routinely offered at our hospital during the study period.
All ECV procedures in our hospital are performed by the Maternal-Fetal Medicine faculty members in a similar fashion. A standard ECV order set was used by all practitioners. Before the procedure, the following clinical parameters are routinely documented: confirmation by ultrasound that the fetus remains in a non-vertex presentation, adequacy of the amniotic fluid index, the absence of active labor and the presence of a reassuring fetal heart rate pattern by external fetal monitoring. Informed consent for the procedure is then obtained. Following the establishment of intravenous access, terbutaline 0.25 mg is administered subcutaneously to all women immediately before the procedure. Epidural anesthesia is not used. The external cephalic procedure is then performed by a single physician with the assistance of a nurse. The assistant monitors fetal presentation and heart rate by ultrasound during the procedure. Before discharge, post-procedure fetal monitoring is performed for a minimum of 1 h. The care of women after ECV was the same as in those pregnancies with spontaneous cephalic presentation.
Before study initiation, an a priori, two-sided, sample size calculation was performed for our primary outcome of cesarean delivery, utilizing prior studies in this area to estimate incidence rates. [4] [5] [6] [7] [8] [9] [10] 13 With an a error of 0.05, we determined that 197 patients and 394 controls, matched in a 2:1 fashion, would yield 80% power to detect a 10% (25 vs 35%) difference in cesarean delivery, assuming a cesarean delivery rate in the control group of approximately 25%. Controls were identified in a retrospective fashion using a quality assurance database of prospectively collected data as described earlier and were matched for parity, history of prior cesarean delivery, gestational age at delivery and induction status. Following identification of a case patient, the subsequent two participants who met the matching criteria were chosen as controls.
Demographic data were compared by ECV status, using conditional logistic regression for categorical variables and the paired t-test for continuous variables, to account for the matched study design. The unadjusted and adjusted odds and 95% confidence interval (CI) for the primary outcome of cesarean delivery were then calculated using conditional logistic regression. Covariates in the multivariate model included diabetes mellitus, pre-eclampsia, cardiac disease and gestational age at delivery. All analyses were performed using Stata, version 9.0 (StataCorp LP, College Station, TX, USA).
Results
During the study period, 914 participants presented with breech presentation at >36 weeks' gestation. ECV was attempted on 420 (46.0%) participants, of which 197 were successful (47.5%). We identified 394 matched controls for a total sample of 591 participants. Though delivery volume remained relatively steady in our medical center during the study period (approximately 250 per month), the average number of ECV attempts during the study period peaked at 3 per month in 2002 and had been decreasing since that time till it reached less than 1 per month.
There were no significant differences between the two groups with respect to maternal age or medical complications including insulin-dependent diabetes, cardiac disease, gestational diabetes mellitus, chronic hypertension or pre-eclampsia (Table 1) . Other demographic factors that may potentially impact the cesarean delivery rate, such as ethnicity and epidural use, were not statistically significantly different between the groups. In contrast, participants who underwent successful ECV had a higher proportion of deliveries at 41 weeks' gestation or later, though not significant.
Among those participants requiring induction of labor, the mean interval from ECV to induction was 13.6 days (range 0 to 38 days). As induction status was one of the matching criteria, there was no difference between the two groups ( Table 1) . Twenty patients (10.2%) underwent induction of labor within 24 h following successful ECV. Within this group, indications for induction included elective (15%), abnormal post-procedure nonstress tests (10%), post-dates (10%), suspected macrosomia (5%) and pre-eclampsia (5%). The remaining indications for induction were unspecified.
Of the women undergoing successful ECV, 83.2% were subsequently delivered vaginally. Despite a slightly higher overall rate of cesarean delivery in the ECV group vs controls (16.8 vs 11.9%), the matched odds ratio (OR) for the primary outcome of cesarean delivery was not statistically different between the two groups, based on a 95% CI that crosses one (OR 1.70; 95% CI 0.98 to 2.97). There was also no statistical difference in the indication for cesarean delivery between the ECV cases and controls (data not shown). When the population was subdivided based on parity, the cesarean rate was higher among nulliparous women, but the matched odds of cesarean delivery showed no statistical difference between the ECV group and controls (Table 2) . No significant statistical difference was found in the rate of operative vaginal delivery between the ECV group and the control group, when the adjusted matched OR was calculated (15.9 vs 8.9%; OR 1.06; 95% CI 0.32 to 3.51). There was no significant increase in fetal or maternal morbidity or mortality in participants following an ECV attempt (whether or not it was successful). There were no Cesarean risk after successful cephalic version C Clock et al statistically significant differences in birth weight, gender, 1-and 5-min Apgar scores, or in the rates of admission to the neonatal intensive care unit between the two groups (Table 3) . Among the women with a history of prior cesarean delivery, the median parity for both the ECV and control groups was 2 (range 1 to 3). Of the nine ECV participants with a prior cesarean delivery, 1 (11.1%) required cesarean delivery compared with 3 (16.7%) in the control group (OR 0.59; 95% CI 0.47 to 7.43). The cesarean delivery in the ECV group was performed in a primaparous woman because of failure to progress. There was only one uterine rupture among all the women with a prior cesarean delivery, which occurred in a control patient who presented in spontaneous labor.
Discussion
Some argue that even if ECV is successful, cesarean delivery is more likely due to malpresentation or due to higher rates of subsequent non-reassuring fetal heart rate testing in labor. However, the existing literature as to whether ECV is associated with an increased cesarean delivery rate at term is divided. [5] [6] [7] [8] [9] [10] [11] [12] These varying conclusions may be related to differences in control groups and matching characteristics. In addition, many studies are limited by small sample sizes.
Our study is one of the largest controlled studies to evaluate the mode of delivery following a successful ECV. In our multivariate model, we did not find a statistically significant increase in the matched odds of cesarean delivery, although the point estimate was consistent with a clinically small, but potentially interesting, increase in cesarean deliveries in the ECV group. This finding raises the possibility that residual confounding differences remained between the two groups, which we could not identify and thus control the possibility that our study was underpowered. Although our success rate of 47% for ECV in our institution was somewhat low, it is consistent with reported rates of 44 to 77%. 2, 4 One notable and somewhat surprising finding of our investigation was the low cesarean delivery rates in both the ECV and the control groups. This is in contrast to the current overall cesarean delivery rate in our hospital of approximately 25% during the study period. This difference may be explained by the relatively low risk profile of our study population, with few concomitant medical problems, such as pregestational and gestational diabetes, chronic hypertension and other pregnancy complications including pre-eclampsia. This apparent low level of maternal risk factors in our study population may be the result of selection bias. Specifically, it is possible that participants who are offered and subsequently undergo ECV are better candidates for the ECV procedure and subsequent vaginal delivery because they are a generally healthy population. The selected controls were thus similarly healthy and relatively of low risk, due to the matching process.
Though the lower-than anticipated cesarean delivery rate was a favorable outcome for both groups, it also limited the power of our study, and thus we cannot exclude a type II error. A post hoc, twosided, sample size calculation was performed showing that our study had 51% power to show the difference that we found (17 vs 12%) and >90% power to show a 50% difference (24 vs 12%), with an a error of 0.05.
Although we had a sample size too small for separate evaluation, our study demonstrated a high rate of successful ECV and subsequent vaginal delivery (88.9%) in participants with a prior cesarean delivery. Many institutions treat prior cesarean as an exclusion criteria for ECV attempt. In three individual studies, de Meeus et al.
14 , Flamm 15 and Schachter et al. 13 reported successful ECV in a total of 105 women with prior cesarean delivery, with rates ranging from 65 to 100%. 14, 15, 13 Of these, 54 to 76% had a successful vaginal delivery, and there was no reported increase in the rate of uterine rupture or dehiscence. In our own study, the higher median parity likely increased the success of subsequent vaginal delivery in both the groups. Despite the limited sample size, these data suggest that an appropriate selection of ECV candidates can result in successful vaginal birth after cesarean without an increased rate of complications.
An interesting observation during our study period was the fluctuation in the number of attempted ECVs each year. As noted, despite a relatively steady delivery volume during the study period, the average number of ECV procedures peaked in 2002 at 3 per month and has subsequently decreased to 1.0, 1.3 and 0. On the basis of the data from our study, the impact of ECV on the broader rate of cesarean delivery may be theoretically estimated. If we assume that there are approximately 3.5 million term, singleton births in the United States each year, of which 3.5% are breech, 122 500 pregnancies would be eligible for ECV. 1, 16 Using the results from our study, 46% of these pregnancies would undergo ECV. If at least 47% of ECV procedures are successful and 83.2% of successful ECV patients are delivered vaginally, 22 161 cesarean deliveries per year could be avoided. Although this may seem to be a small number relative to the number of births annually in the United States, any reduction in the number of patients undergoing primary cesarean delivery will also reduce the number of probable repeat cesarean deliveries in the future. In addition, avoiding the first cesarean section would reduce the number of patients who will have abnormal placentation in a subsequent pregnancy, such as a placenta accreta (leading to hemorrhage and significant operative morbidity) or abnormal implantation (which can be associated with stillbirth).
On the basis of the sample size of our study, our data support the role of ECV as a safe alternative to cesarean delivery for breech presentation at term. It also demonstrates that once an ECV is successfully performed, the patient's likelihood of a successful vaginal delivery is comparable with that of a patient with a spontaneous cephalic presentation, even when the patient has undergone an earlier cesarean delivery.
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Synopsis
Successful external cephalic version does not seem to be associated with increased odds of subsequent cesarean delivery compared with matched controls.
